NUTX (NUTX)
Quantitative Summary
DeterministicStrong operational fundamentals (Piotroski 7/9).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company demonstrates robust fundamental quality, characterized by a highly efficient capital allocation profile with an ROIC of 27.7%, significantly outperforming typical hurdle rates for value creation. This efficiency is underpinned by strong profitability drivers; the DuPont decomposition reveals healthy gross margins at 50.8% combined with net margins of 8.1%, while revenue growth accelerates sharply year-over-year at 82.4%. Qualitative financial integrity appears solid, evidenced by a Piotroski F-Score of 7/9 and a Beneish M-Score of -3.13, which collectively suggest low susceptibility to earnings manipulation and stable operational fundamentals despite the rapid top-line expansion.
Valuation metrics present an apparent divergence between historical performance indicators and intrinsic value models. The current price-to-earnings multiple of 10.2x appears compressed relative to a DCF-derived fair value estimate of $1,247, implying that market pricing may be conservative regarding future cash flow assumptions or growth sustainability. This discrepancy suggests the equity could be undervalued if the high revenue growth rate and margin profile persist without deteriorating operating leverage, though the wide gap between current multiples and model-based targets warrants scrutiny on whether the market is correctly discounting the trajectory of these earnings drivers.
Risk assessment requires careful synthesis of the aggressive growth narrative against potential volatility factors inherent in such a steep expansion curve. While the high Piotroski score indicates financial strength, the sheer velocity of 82.4% revenue growth introduces execution risks that standard valuation multiples may not fully capture if margins compress or liquidity strains emerge during scaling phases. Investors must weigh whether the current P/E compression reflects prudent risk pricing for this growth profile or a market skepticism regarding the durability of these metrics in an unknown sector context, leaving the final assessment dependent on how closely actual future performance aligns with these optimistic projections.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $1520 | $1118 | $878 |
| 3% | $1779 | $1247 | $953 |
| 4% | $2168 | $1419 | $1046 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $1247 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in NUTX to visualize passive redemption contagion across ETFs and collateral stocks.
If NUTX (NUTX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies HUMANA INC (HUM) as the most exposed collateral stock, sharing 1 ETFs with NUTX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
NUTX Ownership Dynamics
ETFs with Highest NUTX Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
NUTX Capital Efficiency
How efficiently does NUTX convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
NUTX converts 85% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 178 | $131.90 | $23,478.2 |
| 2026-05-05 | 366 | $147.17 | $53,864.22 |
| 2026-05-04 | 1,292 | $139.57 | $180,324.44 |
| 2026-05-01 | 761 | $119.20 | $90,711.2 |
| 2026-04-29 | 3,638 | $115.09 | $418,697.42 |
| 2026-04-28 | 1,073 | $110.79 | $118,877.67 |
| 2026-04-27 | 788 | $108.24 | $85,293.12 |
| 2026-04-21 | 95 | $109.28 | $10,381.6 |
| 2026-04-13 | 7,786 | $101.05 | $786,775.3 |
| 2026-04-10 | 7,844 | $105.70 | $829,110.8 |
| 2026-04-09 | 8,076 | $105.04 | $848,303.04 |
| 2026-04-08 | 5,279 | $102.90 | $543,209.1 |
| 2026-04-06 | 9 | $100.92 | $908.28 |
| 2026-04-02 | 327 | $98.44 | $32,189.88 |
| 2026-03-31 | 9,310 | $90.90 | $846,279 |
| 2026-03-26 | 69 | $100.38 | $6,926.22 |
| 2026-03-25 | 2,721 | $99.49 | $270,712.29 |
| 2026-03-23 | 10,471 | $88.99 | $931,814.29 |
| 2026-03-12 | 3,879 | $90.49 | $351,010.71 |
| 2026-03-10 | 17,104 | $98.61 | $1.7M |
| 2026-03-09 | 16,341 | $90.28 | $1.5M |
| 2026-03-06 | 29,258 | $105.34 | $3.1M |
| 2026-03-05 | 10,890 | $108.44 | $1.2M |
| 2026-03-03 | 1,228 | $117.60 | $144,412.8 |
| 2026-02-27 | 6 | $115.77 | $694.62 |
| 2026-02-26 | 1,076 | $108.47 | $116,713.72 |
| 2026-02-19 | 1,881 | $104.51 | $196,583.31 |
| 2026-02-18 | 3,290 | $101.33 | $333,375.7 |
| 2026-02-13 | 294 | $105.02 | $30,875.88 |
| 2026-02-11 | 161 | $101.38 | $16,322.18 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare NUTX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.